Isolation and characterization of adenovirus type 12 E1 host-range mutants defective for growth in nontransformed human cells. 1988

D E Breiding, and C A Edbauer, and J Y Tong, and P Byrd, and R J Grand, and P H Gallimore, and J Williams
Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213.

In order to define the functions of human adenovirus type 12 (Ad12) early region 1 (E1) products in lytic infection and oncogenic transformation we have isolated and phenotypically characterized a set of host-range (hr) mutants of this serotype. These mutants grow efficiently upon HER3 cells, which contain and express type 12 E1 genes, but are restricted for growth upon A549 carcinoma and HeLa cells. Inter- and intratypic complementation analysis, marker-rescue mapping, and DNA sequence analysis have assigned some of the mutations to E1A sequence, and some to the reading frame encoding the E1B 54-kDa (482R) protein. Phenotypic analysis of the E1B mutants in particular has revealed some interesting, and in some cases surprising, findings relating to the roles of that protein in virus-cell interactions. This Ad12 gene product is required, either directly or indirectly, for efficient viral DNA replication in A549 and HeLa cells, unlike its counterpart in type 5 virus. Surprisingly, however, despite the severe defect in viral DNA replication, the synthesis of a few species of viral late proteins continues in cells infected by some of the E1B mutants. In contrast, none of these mutants brings about the inhibition of host-cell protein synthesis characteristic of wild-type virus infection, and with some E1B mutants no viral late proteins are made. Further, in a separate study reported elsewhere, we have demonstrated that the E1B 54-kDa product may also be involved, either directly or indirectly, in positive regulation of both E1A and E1B 19-kDa (163R) gene expression. The molecular and/or physiological bases for these various effects remain to be determined, but our initial results suggest that the E1B 54-kDa protein may carry out multiple regulatory functions during the viral life cycle.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005816 Genetic Complementation Test A test used to determine whether or not complementation (compensation in the form of dominance) will occur in a cell with a given mutant phenotype when another mutant genome, encoding the same mutant phenotype, is introduced into that cell. Allelism Test,Cis Test,Cis-Trans Test,Complementation Test,Trans Test,Allelism Tests,Cis Tests,Cis Trans Test,Cis-Trans Tests,Complementation Test, Genetic,Complementation Tests,Complementation Tests, Genetic,Genetic Complementation Tests,Trans Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000260 Adenoviruses, Human Species of the genus MASTADENOVIRUS, causing a wide range of diseases in humans. Infections are mostly asymptomatic, but can be associated with diseases of the respiratory, ocular, and gastrointestinal systems. Serotypes (named with Arabic numbers) have been grouped into species designated Human adenovirus A-G. APC Viruses,APC Virus,Adenovirus, Human,Human Adenovirus,Human Adenoviruses
D014764 Viral Proteins Proteins found in any species of virus. Gene Products, Viral,Viral Gene Products,Viral Gene Proteins,Viral Protein,Protein, Viral,Proteins, Viral
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications

Related Publications

D E Breiding, and C A Edbauer, and J Y Tong, and P Byrd, and R J Grand, and P H Gallimore, and J Williams
March 1988, Virology,
D E Breiding, and C A Edbauer, and J Y Tong, and P Byrd, and R J Grand, and P H Gallimore, and J Williams
March 1977, Virology,
D E Breiding, and C A Edbauer, and J Y Tong, and P Byrd, and R J Grand, and P H Gallimore, and J Williams
July 1979, Cell,
D E Breiding, and C A Edbauer, and J Y Tong, and P Byrd, and R J Grand, and P H Gallimore, and J Williams
July 1978, The Journal of general virology,
D E Breiding, and C A Edbauer, and J Y Tong, and P Byrd, and R J Grand, and P H Gallimore, and J Williams
May 1978, Virology,
D E Breiding, and C A Edbauer, and J Y Tong, and P Byrd, and R J Grand, and P H Gallimore, and J Williams
April 1981, Journal of virology,
D E Breiding, and C A Edbauer, and J Y Tong, and P Byrd, and R J Grand, and P H Gallimore, and J Williams
April 1984, Journal of virology,
D E Breiding, and C A Edbauer, and J Y Tong, and P Byrd, and R J Grand, and P H Gallimore, and J Williams
January 1989, Intervirology,
D E Breiding, and C A Edbauer, and J Y Tong, and P Byrd, and R J Grand, and P H Gallimore, and J Williams
January 1988, Journal of virology,
D E Breiding, and C A Edbauer, and J Y Tong, and P Byrd, and R J Grand, and P H Gallimore, and J Williams
January 2007, Methods in molecular medicine,
Copied contents to your clipboard!